# James M. McKenney

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/james-m-mckenney/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,772 |
| Field | Lipoproteins and Cardiovascular Health |
| h-index | 56 |
| i10-index | 125 |
| OpenAlex ID | https://openalex.org/A5054320288 |
| Works | 193 |

## Researcher papers

- [National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2](https://scholariq.org/papers/national-lipid-association-recommendations-for-patient-centered-management-of/)
- [National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report](https://scholariq.org/papers/national-lipid-association-recommendations-for-patient-centered-management-of-3/)
- [National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary](https://scholariq.org/papers/national-lipid-association-recommendations-for-patient-centered-management-of-2/)
- [Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II Survey and Implications for Treatment Under the Recent NCEP Writing Group Recommendations](https://scholariq.org/papers/results-of-the-national-cholesterol-education-ncep-program-evaluation-project/)
- [Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists](https://scholariq.org/papers/clinical-utility-of-inflammatory-markers-and-advanced-lipoprotein-testing-advice/)
- [Treatment of High-Risk patients with ezetimibe plus simvastatin Co-Administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III Low-Density lipoprotein cholesterol goals](https://scholariq.org/papers/treatment-of-high-risk-patients-with-ezetimibe-plus-simvastatin-co/)

## Researcher topics

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Cancer, Lipids, and Metabolism](https://scholariq.org/topics/cancer-lipids-and-metabolism/)
- [Pharmaceutical Practices and Patient Outcomes](https://scholariq.org/topics/pharmaceutical-practices-and-patient-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.